These aren't obscure specialty drugs. They're medications taken by millions of Americans every day for common conditions — diabetes, blood clots, arthritis, high cholesterol. The retail prices are shocking, but so are the available discounts that most patients never learn about. For a comprehensive approach to paying less, start with our guide to cheap prescriptions.
Used for: Rheumatoid arthritis, psoriasis, Crohn's disease, ulcerative colitis
Humira was the best-selling drug in the world for 20 years. Biosimilars finally arrived in 2023 — including Hadlima, Hyrimoz, and Cyltezo — at 55-85% lower cost. If you're still on brand Humira, ask your doctor about switching to a biosimilar.
Savings options: AbbVie's Complete savings card ($5/month with insurance), biosimilars ($1,000-$3,000/month), myAbbVie Assist PAP (free for qualifying patients).
Used for: Type 2 diabetes (Ozempic), weight management (Wegovy)
The most talked-about drug in America. We wrote an entire guide: Ozempic cost without insurance.
Savings options: Novo Nordisk savings card ($25/month with qualifying insurance), compounded semaglutide ($150-$350/month), PAP (free for low-income patients).
Used for: Blood clot prevention, atrial fibrillation, DVT/PE treatment
One of the most prescribed blood thinners. No generic available until patents expire (expected late 2026-2028).
Savings options: BMS/Pfizer co-pay card ($10/month with insurance), Pfizer RxPathways PAP (free), Canadian pharmacies ($200-$350/month).
Used for: Blood clot prevention, AFib, DVT/PE
Direct competitor to Eliquis. Generic expected to arrive in 2027.
Savings options: J&J Xarelto savings program ($10/month with insurance), PAP (free), Canadian pharmacies ($200-$300/month).
Used for: Type 2 diabetes, heart failure
SGLT2 inhibitor with proven cardiovascular benefits. Generic expected 2025-2027.
Savings options: Eli Lilly savings card ($10/month with insurance), Lilly Cares PAP (free).
Used for: Type 2 diabetes
Another GLP-1 receptor agonist. Similar efficacy to Ozempic for diabetes management.
Savings options: Lilly savings card ($25/month with insurance), Lilly Cares PAP (free).
Used for: Heart failure
Significantly reduces hospitalization and death from heart failure. No generic yet.
Savings options: Novartis co-pay card ($10/month with insurance), Novartis PAP (free).
Used for: Eczema, asthma, nasal polyps
Biologic for moderate-to-severe atopic dermatitis. One of the fastest-growing drugs by revenue.
Savings options: Dupixent MyWay copay card ($0 with qualifying insurance), Sanofi PAP (free).
Used for: Psoriasis, psoriatic arthritis, Crohn's disease
IL-23 inhibitor biologic. Administered as injection every 3 months (maintenance).
Savings options: AbbVie Complete savings ($0-$5/dose with insurance), myAbbVie Assist PAP (free).
Used for: Type 1 and Type 2 diabetes
The price of insulin has been a national scandal. Recent legislation (Inflation Reduction Act) capped Medicare insulin copays at $35/month. Eli Lilly capped all insulin at $35/month. Walmart's ReliOn brand is $25/vial.
Savings options: $35/month cap (Lilly, Medicare), Walmart ReliOn ($25/vial), manufacturer PAPs (free), state insulin safety net programs.
Regardless of which expensive drug you take, follow this hierarchy:
For the science behind these medications and how they compare to non-prescription alternatives, Health Britannica covers evidence-based chronic disease management.
Several blockbuster drugs are losing patent protection in 2026-2028, which will bring generic competition and massive price drops:
| Drug | Expected Generic | Expected Price Drop |
|---|---|---|
| Eliquis | 2026-2028 | 80-90% |
| Xarelto | 2027 | 80-90% |
| Jardiance | 2025-2027 | 80-90% |
| Entresto | 2026-2027 | 70-85% |
| Ozempic (semaglutide) | 2030s | 80-90% |
When a drug goes generic, it typically becomes available on Walmart's $4 list or Cost Plus Drugs within months. We'll update our generic vs. brand guide as these launch.
The U.S. is the only major country that doesn't negotiate drug prices at a national level (though the Inflation Reduction Act began limited Medicare negotiations in 2025). Drug companies set prices based on what the market will bear, and insurance/PBM middlemen add costs. The same drug often costs 2-10x more in the U.S. than in Canada or Europe.
A biosimilar is the biologic equivalent of a generic drug. Biologics (like Humira, Ozempic) are made from living cells and are more complex than traditional chemical drugs. Biosimilars must demonstrate they're highly similar to the original biologic with no clinically meaningful differences. They're typically 55-85% cheaper than the brand.
No. Federal law prohibits Medicare patients from using manufacturer copay cards or coupons. However, the Inflation Reduction Act capped Medicare Part D out-of-pocket costs at $2,000/year starting in 2025, which helps with expensive drugs. Medicare patients should also check manufacturer PAPs, which some companies offer separately for Medicare enrollees.
Generic launches, new savings programs, and price changes for expensive drugs.